Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription 09.02.2026 1 Antimicrob Agents Chemother 1 J Infect Dis 2 Pediatrics 20 PLoS One 1 Proc Natl Acad Sci U S A 10 Vaccine 2 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. LLORENTE J, Sempere J, Llamosi M, Perez-Garcia C, et al
   Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain.
   Antimicrob Agents Chemother. 2025 Dec 31:e0153025. doi: 10.1128/aac.01530.
   PubMed         Abstract available
   
   

   
   J Infect Dis

2. VILLAFUERTE D, Fall A, Akin E, Werner AP, et al
   Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization.
   J Infect Dis. 2026 Feb 4:jiag069. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Pediatrics

3. GAGO CM, Ruggiero CF, Gundewar A, Rose W, et al
   Parent Perspectives on the Interactive Role of Charitable and Federal Nutrition Assistance.
   Pediatrics. 2026 Jan 6:e2025072664. doi: 10.1542/peds.2025-072664.
   PubMed         Abstract available
   
   
4. SALTHOUSE AL, Tannis A, Rutkowski RE, Weinberg GA, et al
   Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2 Years Hospitalized With RSV.
   Pediatrics. 2026 Jan 8:e2025072578. doi: 10.1542/peds.2025-072578.
   PubMed         Abstract available
   
   

   
   PLoS One

5. BOU-HAMAD I
   Understanding consumer behavior in Lebanon's polycrisis: The role of ethnocentrism, coping ability, and socioeconomic status.
   PLoS One. 2026;21:e0341265.
   PubMed         Abstract available
   
   
6. MCMILLAN M, Beazley R, Vasilunas N, Sullivan TR, et al
   Children and adolescents: Respiratory infection and long-term effects longitudinal study (CARE Study): Study protocol.
   PLoS One. 2026;21:e0341566.
   PubMed         Abstract available
   
   
7. CHURIWAL M, Tompkins K, Streeter G, Litel C, et al
   Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain [D614G] in an outpatient household cohort.
   PLoS One. 2026;21:e0313467.
   PubMed         Abstract available
   
   
8. MERKLEY E, Loewen PJ
   Economic shock and the erosion of COVID-19 precautionary behavior in Canada during the early pandemic.
   PLoS One. 2026;21:e0340685.
   PubMed         Abstract available
   
   
9. AHABWENKI R, Piloya T, Namiiro F, Muzeyi W, et al
   Impact of COVID-19 on New - onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda.
   PLoS One. 2026;21:e0341145.
   PubMed         Abstract available
   
   
10. EDAE CK, Bedada AT, Teklemariam MD, Tolesa MB, et al
    A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia.
    PLoS One. 2026;21:e0340457.
    PubMed         Abstract available
    
    
11. DINERO RE, Monti WB, Kmush BL
    Regional political climate's moderating role in the association between political conservatism and COVID-19 vaccine hesitancy in the United States.
    PLoS One. 2026;21:e0342063.
    PubMed         Abstract available
    
    
12. WU X, Rai SN, Weber GF
    Model-free prognostication of non-linear time series.
    PLoS One. 2026;21:e0341777.
    PubMed         Abstract available
    
    
13. KIM S, Kim K
    Combined association of socioeconomic status and type 2 diabetes with influenza vaccination in older adults: A cross-sectional analysis of the Korea National Health and Examination Survey (2019-2022).
    PLoS One. 2026;21:e0341831.
    PubMed         Abstract available
    
    
14. BRAEYE T, Abrams S, Hens N
    Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity.
    PLoS One. 2026;21:e0328144.
    PubMed         Abstract available
    
    
15. TRAKSEL R, Broen J, van Henten A, Konigs M, et al
    Iodine increases pulmonary type I interferon responses and decreases covid-19 disease severity: Results from an open label randomized clinical trial.
    PLoS One. 2026;21:e0341126.
    PubMed         Abstract available
    
    
16. MOI F, Nguyen VM, Archer R, Namalela T, et al
    The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries.
    PLoS One. 2026;21:e0341964.
    PubMed         Abstract available
    
    
17. MAVROVOUNIOTIS ML
    Use of Kaplan-Meier and Cox regressions in the distribution of length of stay in animal shelters for pre-specified calendar periods: Definition, computation, and examples of dog length of stay in orange county California.
    PLoS One. 2026;21:e0342102.
    PubMed         Abstract available
    
    
18. VAN'T HOFF ST, Helfrich G, Boerman S, Hardeman HA, et al
    Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study.
    PLoS One. 2026;21:e0340889.
    PubMed         Abstract available
    
    
19. DO MH, Nguyen TT, Grote U
    Households' poverty and inequality after the COVID-19: Insights from panel data of face-to-face surveys in Southeast Asia.
    PLoS One. 2026;21:e0341648.
    PubMed         Abstract available
    
    
20. KINDU M, Yenesew MA, Kassie GG
    Infection prevention practices and associated factors among healthcare professionals in West Gojjam Zone public Hospitals Northwest Ethiopia, 2023.
    PLoS One. 2026;21:e0338621.
    PubMed         Abstract available
    
    
21. REID CN, Beckstead JW, Salinas-Miranda AA
    Exploring the influence of COVID-19 stress on mental health among international undergraduate and graduate students: A mixed-methods approach.
    PLoS One. 2026;21:e0336446.
    PubMed         Abstract available
    
    
22. CHIKANYA ER, Chimbari MJ
    Assessing knowledge levels on coronavirus disease (COVID-19) among community members: The influence of community engagement efforts in Seke district, Zimbabwe: A cross-sectional study.
    PLoS One. 2026;21:e0342318.
    PubMed         Abstract available
    
    
23. MIRANDA MF, Alvarez C, Earp J, Gurovich AN, et al
    Eccentric cycling is superior to standard rehabilitation for Post-ICU recovery in COVID-19 survivors.
    PLoS One. 2026;21:e0340965.
    PubMed         Abstract available
    
    
24. ASSAAD M, Chamma N, Mateev M, Rizk R, et al
    Telehealth during and beyond the COVID-19 Pandemic: Evidence from licensed dietitians in an emerging economy.
    PLoS One. 2026;21:e0311330.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. WANG J, Tai W, Wang Z, Dai W, et al
    SARS-CoV-2 S assembly into virions facilitated by host ERM proteins.
    Proc Natl Acad Sci U S A. 2026;123:e2504517123.
    PubMed         Abstract available
    
    

    
    Vaccine

26. WIWE EF, Jorgensen M, Brandt L, Talouzi N, et al
    Spike antibody levels and risk of SARS-CoV-2 reinfection: a two-year cohort study in previously infected adults.
    Vaccine. 2026;74:128194.
    PubMed         Abstract available
    
    
27. ZHANG M, Huang S, Ruan C, Jiang Y, et al
    Anti-vaccination attitudes and behavioral intentions towards three recommended vaccinations among Chinese older adults with chronic diseases: A multicenter cross-sectional study.
    Vaccine. 2026;74:128191.
    PubMed         Abstract available
    
    
28. RENNER TM, Agbayani G, Azizi H, Deschatelets L, et al
    Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA/LNP prime induces robust and balanced immune responses.
    Vaccine. 2026;74:128182.
    PubMed         Abstract available
    
    
29. ALBY-LAURENT F, Ouedrani A, Jateau P, Strullu M, et al
    Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1/2 trial with dose finding study.
    Vaccine. 2026 Jan 7:128130. doi: 10.1016/j.vaccine.2025.128130.
    PubMed         Abstract available
    
    
30. HOBBS M, Marek L, Wiki J, Paynter J, et al
    Examining spatial variation and inequity in COVID-19 immunisation coverage in Aotearoa New Zealand: a nationwide geospatial study.
    Vaccine. 2026;74:128165.
    PubMed         Abstract available
    
    
31. GIDUTHURI JG, Vengiau G, Vutliu V, Manineng C, et al
    Behavioural and social drivers of COVID-19 vaccination in Papua New Guinea: A cross-sectional study.
    Vaccine. 2026;74:128207.
    PubMed         Abstract available
    
    
32. HERRAEZ CARRERA O, Gomez-Romero FJ, Marin Sanchez R, Fernandez Martin J, et al
    Impact of respiratory syncytial virus immunoprophylaxis on paediatric consultations: a time series study in Castilla-La Mancha, Spain (2022-2024).
    Vaccine. 2026;74:128229.
    PubMed         Abstract available
    
    
33. MALLET A, Jaunay LB, Jaury P, Partouche H, et al
    Vaccine refusal during the COVID-19 pandemic: A qualitative study.
    Vaccine. 2026;74:128206.
    PubMed         Abstract available
    
    
34. MADSEN AMR, Schaltz-Buchholzer F, Trebbien R, Roring R, et al
    Evaluating the non-specific effects of BCG vaccination on the immune system and serological response to influenza vaccination in the elderly: A randomised controlled trial.
    Vaccine. 2026;76:128305.
    PubMed         Abstract available
    
    
35. KIM DH, Kim JC, Lee SH, Kim J, et al
    Efficacy of dual administration vaccine of recombinant Newcastle disease virus expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza and viscerotropic Velogenic Newcastle disease virus in broilers.
    Vaccine. 2026;76:128288.
    PubMed         Abstract available
    
    

    
    Virus Res

36. LUO X, Liu H, Kuang H, Xie Y, et al
    Impacts of Delayed Influenza Vaccination on Clinical Outcomes in ICU-Admitted Patients with Influenza: A Retrospective Cohort Study.
    Virus Res. 2026 Feb 3:199700. doi: 10.1016/j.virusres.2026.199700.
    PubMed         Abstract available
    
    
37. NAZKI S, Reine J, Kailath R, Gilbert S, et al
    Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.
    Virus Res. 2026;364:199691.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum